Cargando…

Establishment of a Clinical Nomogram Model to Predict the Progression of COVID-19 to Severe Disease

BACKGROUND: Coronavirus disease 2019 (COVID-19) is a worldwide public health pandemic with a high mortality rate, among severe cases. The disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. It is important to ensure early detection of the virus to curb disease pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Changli, Wang, Guojie, Geng, Yayuan, Guo, Na, Cui, Ning, Liu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179801/
https://www.ncbi.nlm.nih.gov/pubmed/34103920
http://dx.doi.org/10.2147/TCRM.S308961
_version_ 1783703865447677952
author Tu, Changli
Wang, Guojie
Geng, Yayuan
Guo, Na
Cui, Ning
Liu, Jing
author_facet Tu, Changli
Wang, Guojie
Geng, Yayuan
Guo, Na
Cui, Ning
Liu, Jing
author_sort Tu, Changli
collection PubMed
description BACKGROUND: Coronavirus disease 2019 (COVID-19) is a worldwide public health pandemic with a high mortality rate, among severe cases. The disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. It is important to ensure early detection of the virus to curb disease progression to severe COVID-19. This study aims to establish a clinical-nomogram model to predict the progression to severe COVID-19 in a timely and efficient manner. METHODS: This retrospective study included 202 patients with COVID-19 who were admitted to the Fifth Affiliated Hospital of Sun Yat-sen University and Shiyan Taihe Hospital from January 17 to April 30, 2020. The patients were randomly assigned to the training dataset (n = 163, with 43 progressing to severe COVID-19) or the validation dataset (n = 39, with 10 progressing to severe COVID-19) at a ratio of 8:2. The optimal subset algorithm was applied to filter for the clinical factors most relevant to the disease progression. Based on these factors, the logistic regression model was fit to distinguish severe (including severe and critical cases) from non-severe (including mild and moderate cases) COVID-19. Sensitivity, specificity, and area under the curve (AUC) were calculated using the R software package to evaluate prediction performance. A clinical nomogram was established and performance assessed using the discrimination curve. RESULTS: Risk factors, including demographic data, symptoms, laboratory and image findings, were recorded for the 202 patients. Eight of the 53 variables that were entered into the selection process were selected via the best subset algorithm to establish the predictive model; they included gender, age, BMI, CRP, D-dimer, TP, ALB, and involved-lobe. AUC, sensitivity, and specificity were 0.91, 0.84 and 0.86 for the training dataset, and 0.87, 0.66, and 0.80 for the validation dataset. CONCLUSION: We established an efficient and reliable clinical nomogram model which showed that gender, age, and initial indexes including BMI, CRP, D-dimer, involved-lobe, TP, and ALB could predict the risk of progression to severe COVID-19.
format Online
Article
Text
id pubmed-8179801
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-81798012021-06-07 Establishment of a Clinical Nomogram Model to Predict the Progression of COVID-19 to Severe Disease Tu, Changli Wang, Guojie Geng, Yayuan Guo, Na Cui, Ning Liu, Jing Ther Clin Risk Manag Original Research BACKGROUND: Coronavirus disease 2019 (COVID-19) is a worldwide public health pandemic with a high mortality rate, among severe cases. The disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. It is important to ensure early detection of the virus to curb disease progression to severe COVID-19. This study aims to establish a clinical-nomogram model to predict the progression to severe COVID-19 in a timely and efficient manner. METHODS: This retrospective study included 202 patients with COVID-19 who were admitted to the Fifth Affiliated Hospital of Sun Yat-sen University and Shiyan Taihe Hospital from January 17 to April 30, 2020. The patients were randomly assigned to the training dataset (n = 163, with 43 progressing to severe COVID-19) or the validation dataset (n = 39, with 10 progressing to severe COVID-19) at a ratio of 8:2. The optimal subset algorithm was applied to filter for the clinical factors most relevant to the disease progression. Based on these factors, the logistic regression model was fit to distinguish severe (including severe and critical cases) from non-severe (including mild and moderate cases) COVID-19. Sensitivity, specificity, and area under the curve (AUC) were calculated using the R software package to evaluate prediction performance. A clinical nomogram was established and performance assessed using the discrimination curve. RESULTS: Risk factors, including demographic data, symptoms, laboratory and image findings, were recorded for the 202 patients. Eight of the 53 variables that were entered into the selection process were selected via the best subset algorithm to establish the predictive model; they included gender, age, BMI, CRP, D-dimer, TP, ALB, and involved-lobe. AUC, sensitivity, and specificity were 0.91, 0.84 and 0.86 for the training dataset, and 0.87, 0.66, and 0.80 for the validation dataset. CONCLUSION: We established an efficient and reliable clinical nomogram model which showed that gender, age, and initial indexes including BMI, CRP, D-dimer, involved-lobe, TP, and ALB could predict the risk of progression to severe COVID-19. Dove 2021-06-01 /pmc/articles/PMC8179801/ /pubmed/34103920 http://dx.doi.org/10.2147/TCRM.S308961 Text en © 2021 Tu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Tu, Changli
Wang, Guojie
Geng, Yayuan
Guo, Na
Cui, Ning
Liu, Jing
Establishment of a Clinical Nomogram Model to Predict the Progression of COVID-19 to Severe Disease
title Establishment of a Clinical Nomogram Model to Predict the Progression of COVID-19 to Severe Disease
title_full Establishment of a Clinical Nomogram Model to Predict the Progression of COVID-19 to Severe Disease
title_fullStr Establishment of a Clinical Nomogram Model to Predict the Progression of COVID-19 to Severe Disease
title_full_unstemmed Establishment of a Clinical Nomogram Model to Predict the Progression of COVID-19 to Severe Disease
title_short Establishment of a Clinical Nomogram Model to Predict the Progression of COVID-19 to Severe Disease
title_sort establishment of a clinical nomogram model to predict the progression of covid-19 to severe disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179801/
https://www.ncbi.nlm.nih.gov/pubmed/34103920
http://dx.doi.org/10.2147/TCRM.S308961
work_keys_str_mv AT tuchangli establishmentofaclinicalnomogrammodeltopredicttheprogressionofcovid19toseveredisease
AT wangguojie establishmentofaclinicalnomogrammodeltopredicttheprogressionofcovid19toseveredisease
AT gengyayuan establishmentofaclinicalnomogrammodeltopredicttheprogressionofcovid19toseveredisease
AT guona establishmentofaclinicalnomogrammodeltopredicttheprogressionofcovid19toseveredisease
AT cuining establishmentofaclinicalnomogrammodeltopredicttheprogressionofcovid19toseveredisease
AT liujing establishmentofaclinicalnomogrammodeltopredicttheprogressionofcovid19toseveredisease